Verrica Pharmaceuticals Inc. (VRCA) — Dilution Risk Analysis

Current Snapshot

Verrica Pharmaceuticals Inc. (VRCA) has a DilutionWatch score of 66/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
17,178,786 Source
Public Float
7,896,744 Source
Float as % of Outstanding
46.0%

Dilution Risk Score

Score: 66/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: 3 1, XBRL 2.

FormFiledAccession
3 2026-01-26 0002101167-26-000002
xbrl 2024-12-31 xbrl-5578-xbrl_convertible
xbrl 2024-05-14 xbrl-5578-xbrl_warrant

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 2 months Source
Three-year share count growth 226.71% Source

DilutionWatch Analysis

Risk Level
HIGH (Score: 66/10) Source
Cash Runway
2 months Source
Share Count Growth (3-Year)
226.71% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.